Inflammation and resistance to erythropoietin in hemodialysis patients

Acta Haematologica

Volumn 108, Issue 3, 2002, Pages 168-170

  Nitta, Kosaku ^a   Akiba, Takashi ^a   Takei, Takashi ^a   Kimata, Naoki ^a   Watanabe, Yoshihiko ^a   Oba, Takashi ^b   Uchida, Keiko ^a   Kawashima, Akira ^a   Yumura, Wako ^a   Kabaya, Takashi ^b   Nihei, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Minami Senju Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CHONDROITIN SULFATE IRON; CREATININE; EPOSIN; ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; INTERLEUKIN 6; IRON; NITROGEN; PARATHYROID HORMONE; POLYSULFONE; SERUM ALBUMIN; TRANSFERRIN; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; ARTIFICIAL KIDNEY; BODY MASS; CHRONIC GLOMERULONEPHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HORMONE DETERMINATION; HUMAN; IMMUNORADIOMETRIC ASSAY; INFLAMMATION; KIDNEY FAILURE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANK SUM TEST; STUDENT T TEST; UREA NITROGEN BLOOD LEVEL;

AGED; DRUG RESISTANCE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 18744391364     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064704     Document Type: Article

References (9)

1. Macdougall IC: Poor response to erythropoie-tin: Practical guideline on investigation and management. Nephrol Dial Transplant 1995; 10:607-614.
2. Muirhead N, Bargman J, Burgess E, Jindal KK, Levin A, Nolin L, Parfrey P: Evidence-based recommendations for the clinical use of recombinant human erythropoietin. Am J Kidney Dis 1995;26:S1-S24.
3. Trey JE, Kushner I: The acute phase response and the hematopoietic system: The role of cytokines. Crit Rev Oncol Hematol 1995;21:1-18.
4. Kabaya T, Nitta K, Kawashima A, Kimura H, Nihei H: An increased serum level of parathyroid hormone is a risk factor for aortosclerosis in hemodialysis patients. Nephron 2000;86:213-214.
5. Goicoechea M, Martin J, De Sequera P, Guiroga JA, Ortiz A, Carreno, Carmelo C: Role of cytokines in the response to erythropoietin in hemodialysis patients. Kidney Int 1998;54:1337-1343.
6. Barany P, Divino Filho JC, Bergstrom J: High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 1997;29:565-568.
7. Owen WF, Lowrie EG: C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998;54:627-636.
8. Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999;33:63-72.
9. Epstein FH: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.